Clinical Trials Browser

Phase 1/2 × ensartinib × 90 days × Clear all

NCT07448116 2026-03-04

Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.

Phase 1/2 Recruiting

Solid Advanced Tumor

NCT07354061 2026-01-21

TD-ENSEMBLE

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung